Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma

Table 2

Clinical characteristics of 9 patients with bacterial infection within 7 days after TACE and/or RFA.

Number	Gender	Age	Treatment	Diagnosis of infection	Bacterial etiology	Days of infection detected after TACE and/or RFA	PCT on day of fever	Peak PCT within 7 days	Outcome of infection
1	M	57	TACE	Cholecystitis	Bile, E. hirae	4	2.58	2.58	Cured
2	M	83	TACE	Pneumonia	—	5	0.72	0.72	Cured
3	M	55	TACE	UTI	—	4	0.23	2.40	Cured
4	M	75	TACE	Bacteremia, primary	Blood, E. coli	2	1.55	1.70	Cured
5	M	79	TACE	UTI	—	3	1.19	1.19	Cured
6	M	73	TACE	Pneumonia	Sputum, E. coli	7	0.21	0.24	Cured
7	F	77	Sequential TACE/RFA	Liver abscess	Blood, E. casseliflavus	7	0.16	0.59	Transferred to another hospital
8	M	71	TACE	Bacteremia, cholangitis	Blood, E. gallinarum	1	0.15	0.55	Cured
9	F	65	RFA	Bacteremia, RFA site cutaneous abscess	Blood, S. aureus	1	0.08	0.17	Cured

TACE: transarterial chemoembolization; RFA: radiofrequency ablation; UTI: urinary tract infection; PCT: procalcitonin.